Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004408105 | SCV004900469 | uncertain significance | not specified | 2023-09-29 | criteria provided, single submitter | clinical testing | The c.409C>T (p.R137W) alteration is located in exon 4 (coding exon 2) of the LRTM2 gene. This alteration results from a C to T substitution at nucleotide position 409, causing the arginine (R) at amino acid position 137 to be replaced by a tryptophan (W). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |